Report cover image

Global Capecitabine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 199 Pages
SKU # APRC20277260

Description

Summary

According to APO Research, The global Capecitabine Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Capecitabine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Capecitabine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Capecitabine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Capecitabine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Capecitabine Tablets include Chia Tai-Tianqing Pharmaceutical, Chengdu Easton Biopharmaceuticals, Shanghai Sine Pharmaceutical, Shandong New Time Pharmaceutical, Qilu Pharmaceutical, Roche, Teva Pharmaceutical, Sun Pharma and Eugia Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Capecitabine Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Capecitabine Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Capecitabine Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Capecitabine Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Capecitabine Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Capecitabine Tablets sales, projected growth trends, production technology, application and end-user industry.

Capecitabine Tablets Segment by Company

Chia Tai-Tianqing Pharmaceutical
Chengdu Easton Biopharmaceuticals
Shanghai Sine Pharmaceutical
Shandong New Time Pharmaceutical
Qilu Pharmaceutical
Roche
Teva Pharmaceutical
Sun Pharma
Eugia Pharma
Dr. Reddy's Laboratories
Accord Healthcare
Capecitabine Tablets Segment by Type

150mg
500mg
Capecitabine Tablets Segment by Application

Colon Cancer
Breast Cancer
Stomach Cancer
Capecitabine Tablets Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Capecitabine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Capecitabine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Capecitabine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Capecitabine Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Capecitabine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Capecitabine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Capecitabine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

199 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Capecitabine Tablets Market Size, 2020 VS 2024 VS 2031
1.3 Global Capecitabine Tablets Market Size Estimates and Forecasts (2020-2031)
1.4 Global Capecitabine Tablets Sales Estimates and Forecasts (2020-2031)
1.5 Global Capecitabine Tablets Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Capecitabine Tablets Market Dynamics
2.1 Capecitabine Tablets Industry Trends
2.2 Capecitabine Tablets Industry Drivers
2.3 Capecitabine Tablets Industry Opportunities and Challenges
2.4 Capecitabine Tablets Industry Restraints
3 Capecitabine Tablets Market by Manufacturers
3.1 Global Capecitabine Tablets Revenue by Manufacturers (2020-2025)
3.2 Global Capecitabine Tablets Sales by Manufacturers (2020-2025)
3.3 Global Capecitabine Tablets Average Sales Price by Manufacturers (2020-2025)
3.4 Global Capecitabine Tablets Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Capecitabine Tablets Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Capecitabine Tablets Manufacturers, Product Type & Application
3.7 Global Capecitabine Tablets Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Capecitabine Tablets Market CR5 and HHI
3.8.2 Global Top 5 and 10 Capecitabine Tablets Players Market Share by Revenue in 2024
3.8.3 2024 Capecitabine Tablets Tier 1, Tier 2, and Tier 3
4 Capecitabine Tablets Market by Type
4.1 Capecitabine Tablets Type Introduction
4.1.1 150mg
4.1.2 500mg
4.2 Global Capecitabine Tablets Sales by Type
4.2.1 Global Capecitabine Tablets Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Capecitabine Tablets Sales by Type (2020-2031)
4.2.3 Global Capecitabine Tablets Sales Market Share by Type (2020-2031)
4.3 Global Capecitabine Tablets Revenue by Type
4.3.1 Global Capecitabine Tablets Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Capecitabine Tablets Revenue by Type (2020-2031)
4.3.3 Global Capecitabine Tablets Revenue Market Share by Type (2020-2031)
5 Capecitabine Tablets Market by Application
5.1 Capecitabine Tablets Application Introduction
5.1.1 Colon Cancer
5.1.2 Breast Cancer
5.1.3 Stomach Cancer
5.2 Global Capecitabine Tablets Sales by Application
5.2.1 Global Capecitabine Tablets Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Capecitabine Tablets Sales by Application (2020-2031)
5.2.3 Global Capecitabine Tablets Sales Market Share by Application (2020-2031)
5.3 Global Capecitabine Tablets Revenue by Application
5.3.1 Global Capecitabine Tablets Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Capecitabine Tablets Revenue by Application (2020-2031)
5.3.3 Global Capecitabine Tablets Revenue Market Share by Application (2020-2031)
6 Global Capecitabine Tablets Sales by Region
6.1 Global Capecitabine Tablets Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Capecitabine Tablets Sales by Region (2020-2031)
6.2.1 Global Capecitabine Tablets Sales by Region (2020-2025)
6.2.2 Global Capecitabine Tablets Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Capecitabine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Capecitabine Tablets Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Capecitabine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Capecitabine Tablets Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Capecitabine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Capecitabine Tablets Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Capecitabine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Capecitabine Tablets Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Capecitabine Tablets Revenue by Region
7.1 Global Capecitabine Tablets Revenue by Region
7.1.1 Global Capecitabine Tablets Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Capecitabine Tablets Revenue by Region (2020-2025)
7.1.3 Global Capecitabine Tablets Revenue by Region (2026-2031)
7.1.4 Global Capecitabine Tablets Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Capecitabine Tablets Revenue (2020-2031)
7.2.2 North America Capecitabine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Capecitabine Tablets Revenue (2020-2031)
7.3.2 Europe Capecitabine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Capecitabine Tablets Revenue (2020-2031)
7.4.2 Asia-Pacific Capecitabine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Capecitabine Tablets Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Capecitabine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Chia Tai-Tianqing Pharmaceutical
8.1.1 Chia Tai-Tianqing Pharmaceutical Comapny Information
8.1.2 Chia Tai-Tianqing Pharmaceutical Business Overview
8.1.3 Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Product Portfolio
8.1.5 Chia Tai-Tianqing Pharmaceutical Recent Developments
8.2 Chengdu Easton Biopharmaceuticals
8.2.1 Chengdu Easton Biopharmaceuticals Comapny Information
8.2.2 Chengdu Easton Biopharmaceuticals Business Overview
8.2.3 Chengdu Easton Biopharmaceuticals Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Chengdu Easton Biopharmaceuticals Capecitabine Tablets Product Portfolio
8.2.5 Chengdu Easton Biopharmaceuticals Recent Developments
8.3 Shanghai Sine Pharmaceutical
8.3.1 Shanghai Sine Pharmaceutical Comapny Information
8.3.2 Shanghai Sine Pharmaceutical Business Overview
8.3.3 Shanghai Sine Pharmaceutical Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Shanghai Sine Pharmaceutical Capecitabine Tablets Product Portfolio
8.3.5 Shanghai Sine Pharmaceutical Recent Developments
8.4 Shandong New Time Pharmaceutical
8.4.1 Shandong New Time Pharmaceutical Comapny Information
8.4.2 Shandong New Time Pharmaceutical Business Overview
8.4.3 Shandong New Time Pharmaceutical Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Shandong New Time Pharmaceutical Capecitabine Tablets Product Portfolio
8.4.5 Shandong New Time Pharmaceutical Recent Developments
8.5 Qilu Pharmaceutical
8.5.1 Qilu Pharmaceutical Comapny Information
8.5.2 Qilu Pharmaceutical Business Overview
8.5.3 Qilu Pharmaceutical Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Qilu Pharmaceutical Capecitabine Tablets Product Portfolio
8.5.5 Qilu Pharmaceutical Recent Developments
8.6 Roche
8.6.1 Roche Comapny Information
8.6.2 Roche Business Overview
8.6.3 Roche Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Roche Capecitabine Tablets Product Portfolio
8.6.5 Roche Recent Developments
8.7 Teva Pharmaceutical
8.7.1 Teva Pharmaceutical Comapny Information
8.7.2 Teva Pharmaceutical Business Overview
8.7.3 Teva Pharmaceutical Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Teva Pharmaceutical Capecitabine Tablets Product Portfolio
8.7.5 Teva Pharmaceutical Recent Developments
8.8 Sun Pharma
8.8.1 Sun Pharma Comapny Information
8.8.2 Sun Pharma Business Overview
8.8.3 Sun Pharma Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Sun Pharma Capecitabine Tablets Product Portfolio
8.8.5 Sun Pharma Recent Developments
8.9 Eugia Pharma
8.9.1 Eugia Pharma Comapny Information
8.9.2 Eugia Pharma Business Overview
8.9.3 Eugia Pharma Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Eugia Pharma Capecitabine Tablets Product Portfolio
8.9.5 Eugia Pharma Recent Developments
8.10 Dr. Reddy's Laboratories
8.10.1 Dr. Reddy's Laboratories Comapny Information
8.10.2 Dr. Reddy's Laboratories Business Overview
8.10.3 Dr. Reddy's Laboratories Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Dr. Reddy's Laboratories Capecitabine Tablets Product Portfolio
8.10.5 Dr. Reddy's Laboratories Recent Developments
8.11 Accord Healthcare
8.11.1 Accord Healthcare Comapny Information
8.11.2 Accord Healthcare Business Overview
8.11.3 Accord Healthcare Capecitabine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Accord Healthcare Capecitabine Tablets Product Portfolio
8.11.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Capecitabine Tablets Value Chain Analysis
9.1.1 Capecitabine Tablets Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Capecitabine Tablets Production Mode & Process
9.2 Capecitabine Tablets Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Capecitabine Tablets Distributors
9.2.3 Capecitabine Tablets Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.